Long noncoding RNA LHFPL3-AS2 suppresses metastasis of non-small cell lung cancer by interacting with SFPQ to

Zhuoan Cheng1, Chunlai Lu2, Hui Wang1

  • 1State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.

Cancer Letters
|February 1, 2022
PubMed

Insights

This study identifies LHFPL3-AS2 as a novel long noncoding RNA (lncRNA) significantly decreased in non-small cell lung cancer (NSCLC). Lower LHFPL3-AS2 levels correlate with poor prognosis and promote NSCLC cell invasion and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Lung cancer is a leading cause of cancer mortality globally.
  • The role of long noncoding RNAs (lncRNAs) in non-small cell lung cancer (NSCLC) pathogenesis is not fully understood.
  • Identifying novel molecular markers and therapeutic targets is crucial for improving NSCLC outcomes.

Purpose of the Study:

  • To investigate the expression profile and functional role of lncRNAs in NSCLC.
  • To identify novel lncRNAs associated with NSCLC progression and patient survival.
  • To elucidate the molecular mechanism underlying the function of a newly identified lncRNA in NSCLC.

Main Methods:

  • Genome-wide lncRNA expression profiling using Affymetrix Gene Chip Human Transcriptome Array 2.0 in 37 paired NSCLC tissues and adjacent nontumorous tissues.
  • Validation of lncRNA expression in an additional 93 paired NSCLC samples.
  • In vitro and in vivo assays to assess the functional impact of LHFPL3-AS2 on NSCLC cell invasion and metastasis.
  • Mechanistic studies involving RNA-protein interactions, promoter binding assays, and gene expression analysis.

Main Results:

  • A novel lncRNA, LHFPL3-AS2, was identified and found to be significantly downregulated in NSCLC tissues.
  • Low LHFPL3-AS2 expression levels were strongly correlated with advanced TNM stage, metastasis, and poor overall survival in NSCLC patients.
  • Overexpression of LHFPL3-AS2 suppressed NSCLC cell invasion and metastasis both in vitro and in vivo.
  • Downregulation of LHFPL3-AS2 led to reduced interaction with SFPQ, increased SFPQ binding to the TXNIP promoter, and subsequent transcriptional repression of TXNIP, promoting NSCLC cell migration and invasion.
  • LHFPL3-AS2 expression was regulated by EGR1 under hypoxic conditions.

Conclusions:

  • LHFPL3-AS2 is a novel tumor suppressor lncRNA in NSCLC, with its downregulation contributing to tumor progression.
  • LHFPL3-AS2 exerts its tumor-suppressive function by modulating the SFPQ-TXNIP axis.
  • LHFPL3-AS2 may serve as a potential prognostic biomarker and therapeutic target for NSCLC.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.1K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
6.8K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.1K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.0K